Skip to main navigation
Molecular Partners

> Top Menu

  • Partnering
  • Careers
  • Contact Us

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • Email Alerts
      • Contact IR

> Top Menu

  • Partnering
  • Careers
  • Contact Us

> Investor Relations

  • About Us
  • DARPin Biology
  • The DARPin Platform
  • Pipeline
  • Investors
    • « Back
    • Overview
    • News & Events
      • « Back
      • News Releases
      • Events
      • Presentations
    • Scientific Documents
    • Stock Information
      • « Back
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • « Back
      • Documents & Charters
      • Management Team & Board of Directors
      • Committee Composition
      • Major Shareholders
      • Management Transactions
    • ESG Overview
    • Ethics & Compliance
    • Financials & Filings
      • « Back
      • SEC Filings
      • Financial Reports
    • General Meeting
    • IR Resources
      • « Back
      • Email Alerts
      • Contact IR

Presentations

Presentations

December 15, 2021
Oncology Day 2021 Presentation
November 17, 2021
MP Corporate Presentation
October 20, 2021
Pre-clinical data of ensovibep, a multi-specific DARPin therapeutic with high potency against all frequent SARS-CoV-2 variants
August 26, 2021
H1 2021 Results and Corporate Update
March 9, 2021
H.C. Wainwright Global Life Sciences Conference
March 2, 2021
Cowen 41st Annual Health Care Conference
February 25, 2021
Leerink 10th Annual Global Healthcare Conference
February 5, 2021
MP FY 2020 presentation and webcast 2:00 pm CET, Molecular Partners HQ, Schlieren
January 14, 2021
JP Morgan 39th Annual Virtual Healthcare Conference
January 13, 2021
Baader Helvea Swiss Equities Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page next ›
  • Last page last »

Investors

> Sidebar Menu

  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Scientific Documents
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team & Board of Directors
    • Committee Composition
    • Major Shareholders
    • Management Transactions
  • ESG Overview
  • Ethics & Compliance
  • Financials & Filings
    • SEC Filings
    • Financial Reports
  • General Meeting
  • IR Resources
    • Email Alerts
    • Contact IR

> Footer Menu

  • Cookie Notice
  • Privacy & Disclaimer
  • Contact Us

> Footer Social

© 2023 Molecular Partners.